Breaking News Instant updates and real-time market news.

IMGN

ImmunoGen

$5.13

-0.36 (-6.56%)

06:33
02/08/19
02/08
06:33
02/08/19
06:33

ImmunoGen sees FY19 revenue $40M-$45M, consensus $64.43M

Sees FY19 operating expenses $265M-$270M. Sees cash and cash equivalents at December 31 $135M-$140M.

  • 08

    Feb

IMGN ImmunoGen
$5.13

-0.36 (-6.56%)

12/02/18
PIPR
12/02/18
NO CHANGE
Target $14
PIPR
Overweight
'Solid' early single agent activity for ImmunoGen '632, says Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro notes that ImmunoGen presented updates from the Phase I trials of both IMGN632 and IMGN779in r/r AML and BPDCN at ASH this weekend. While the aanalyst acknowledges that some may be disappointed with the slight dip in CR/CRi rate for '632 and the lack of dose response, he finds the clear anti-leukemic activity at the lower, more tolerable doses notable and sees this as a positive first full look for this program. '779 still looks to be struggling to find an active dose, Catanzarro contends, adding that he is unsure whether higher doses will elicit enough of an increase in activity without increased toxicity that would warrant further monotherapy development. He reiterates an Overweight rating and $14 price target on the shares.
11/27/18
HCWC
11/27/18
NO CHANGE
HCWC
Buy
ImmunoGen CFO resignation not based on current role, says H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay says the resignation of ImmunoGen (IMGN) CFO David Johnston after the executive was found guilty for civil securities fraud has little to do with the execution of his current responsibilities, but a reflection of his tenure with Aveo Pharmaceuticals (AVEO) pharmaceuticals between 2007 and 2012. Given that a potential guilty verdict was always a possibility, the analyst anticipates a potential replacement "in the not so distant future." With ImmunoGen having made "significant strides" over the past five years, and now closer to commercialization with mirvetuximab Phase 3 readout anticipated during the first half of 2019, any potential replacement might come with prior oncology commercialization experience, and might be a better fit with future needs of the company, Chattopadhyay tells investors in a research note titled "Water Under the old AVEO Bridge." He admits, however, that the resignation is publicity ImmunoGen "could have done without." Chattopadhyay keeps a Buy rating on ImmunoGen with an $18 price target.
11/01/18
PIPR
11/01/18
NO CHANGE
Target $15
PIPR
Overweight
ImmunoGen data give 'very positive' first look at IMGN632, says Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro said the abstract for IMGN632 to be presented by ImmunoGen at the ASH meeting on its Phase 1 trial of IMGN632 in relapsed/refractory acute myeloid leukemia gives a "very positive first look," though he adds that he views the program as carrying significant clinical risk given the novel payload and prior failure of a similar drug. Catanzaro has an Overweight rating and $15 price target on ImmunoGen shares.
09/17/18
GUGG
09/17/18
INITIATION
GUGG
Guggenheim calls Array, Deciphera, ImmunoGen top biotech picks
Guggenheim initiated coverage of the biotechnology sector, initiating and assuming coverage of 17 biotechnology stocks, and saying it is bullish on the sector longer term and expects continued growth. The firm's coverage focuses on the oncology therapeutic category, with Guggenheim calling Array Biopharma (ARRY), Deciphera Pharmaceuticals (DCPH), and ImmunoGen (IMGN), which all have key catalysts coming in the first half or 2019, its top picks.

TODAY'S FREE FLY STORIES

10:02
07/16/19
07/16
10:02
07/16/19
10:02
General news
Housing Market Index data reported »

July Housing Market Index…

10:02
07/16/19
07/16
10:02
07/16/19
10:02
General news
Business Inventories data reported »

May Business Inventories…

GS

Goldman Sachs

$216.98

5.43 (2.57%)

10:01
07/16/19
07/16
10:01
07/16/19
10:01
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman Sachs says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

DIS

Disney

$144.63

-0.42 (-0.29%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Periodicals
ESPN to launch daily morning podcast in October, Washington Post reports »

ESPN is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

COE

China Online Education

$6.84

(0.00%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
China Online Education falls -7.4% »

China Online Education is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRTG

Heritage Insurance

$15.01

-0.94 (-5.89%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
Heritage Insurance falls -5.6% »

Heritage Insurance is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

UGAZ

VelocityShares 3x Long Natural Gas ETN

$16.45

-1.53 (-8.51%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -8.6% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTM

Tata Motors

$12.29

0.63 (5.40%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
Tata Motors rises 5.4% »

Tata Motors is up 5.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$150.60

11.75 (8.46%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 8.3% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRN

Blue Apron

$9.09

1.44 (18.82%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
Blue Apron rises 18.8% »

Blue Apron is up 18.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

REKR

Rekor Systems

$2.53

0.21 (9.05%)

, NVDA

Nvidia

$165.73

-1.51 (-0.90%)

09:58
07/16/19
07/16
09:58
07/16/19
09:58
Hot Stocks
Rekor Systems reports joining NVIDIA Metropolis Software Partner Program »

Rekor Systems (REKR)…

REKR

Rekor Systems

$2.53

0.21 (9.05%)

NVDA

Nvidia

$165.73

-1.51 (-0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

JBHT

J.B. Hunt

$99.00

6.5 (7.03%)

, R

Ryder

$58.12

1.39 (2.45%)

09:55
07/16/19
07/16
09:55
07/16/19
09:55
Options
Early notable gainers among liquid option names on July 16th »

Notable gainers among…

JBHT

J.B. Hunt

$99.00

6.5 (7.03%)

R

Ryder

$58.12

1.39 (2.45%)

SCHW

Charles Schwab

$41.90

1.62 (4.02%)

FDX

FedEx

$171.00

3.13 (1.86%)

GS

Goldman Sachs

$214.69

3.14 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 19

    Jul

  • 30

    Jul

  • 30

    Jul

  • 31

    Jul

  • 26

    Aug

  • 17

    Sep

  • 27

    Oct

  • 13

    Nov

GS

Goldman Sachs

$214.61

3.06 (1.45%)

09:54
07/16/19
07/16
09:54
07/16/19
09:54
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman Sachs says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

SBUX

Starbucks

$90.02

-0.13 (-0.14%)

09:54
07/16/19
07/16
09:54
07/16/19
09:54
Upgrade
Starbucks rating change at OTR Global »

Starbucks upgraded at OTR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GS

Goldman Sachs

$213.56

2.01 (0.95%)

, TW

Tradeweb Markets

$47.40

(0.00%)

09:51
07/16/19
07/16
09:51
07/16/19
09:51
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs, Tradeweb Markets »

Goldman Sachs CFO says…

GS

Goldman Sachs

$213.56

2.01 (0.95%)

TW

Tradeweb Markets

$47.40

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 08

    Aug

09:50
07/16/19
07/16
09:50
07/16/19
09:50
General news
Breaking General news story  »

Atlanta Federal Reserve…

JNJ

Johnson & Johnson

$132.30

-2.37 (-1.76%)

09:49
07/16/19
07/16
09:49
07/16/19
09:49
Hot Stocks
Johnson & Johnson says continues to invest in R&D at 'competitive levels' »

Says: Expects to invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 09

    Sep

  • 16

    Sep

IMRN

Immuron

$6.62

3.78 (133.10%)

09:48
07/16/19
07/16
09:48
07/16/19
09:48
Hot Stocks
Immuron jumps after reporting FY19 sales of A$2.6M »

Immuron announced earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$146.09

0.735 (0.51%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Recommendations
Twilio analyst commentary at JMP Securities »

JMP maintains Outperform…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

SPAR

Spartan Motors

$11.68

1.77 (17.86%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
Spartan Motors receives 2,237-unit walk-in-van order from e-commerce company »

Spartan Fleet Vehicles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

LEA

Lear

$127.00

-8.08 (-5.98%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
Lear falls -6.3% »

Lear is down -6.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ARW

Arrow Electronics

$64.20

-4.62 (-6.71%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
Arrow Electronics falls -6.6% »

Arrow Electronics is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$16.31

-1.67 (-9.29%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -9.3% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTM

Tata Motors

$12.25

0.59 (5.06%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
Tata Motors rises 4.8% »

Tata Motors is up 4.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

APRN

Blue Apron

$8.37

0.72 (9.41%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
Blue Apron rises 10.3% »

Blue Apron is up 10.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.